Around 1 in 5 people inherit a raised level of a sticky particle called Lp(a) [or lipoprotein(a)] that can increase their risk of heart disease and heart damage.1

You could be one of them. There are currently no approved medications that directly target Lp(a) levels, but we want to change that. If you’re taking medication for your heart health and either have or are at risk of developing heart disease, contact our study team to learn more about getting your Lp(a) level tested and the opportunity to take part in important clinical research. This could be your chance to potentially target a risk factor that is unable to be controlled with lifestyle changes and other medicines.

1. Rhainds D, Brodeur MR, Tardif JC. Lipoprotein (a): When to measure and how to treat? Curr Atheroscler Rep. 2021;23(9):51. Doi:10.1007/s11883-021-00951-2.

A clinical study is research involving people to understand human health and disease. Clinical studies look at specific medical treatments to see if they are safe and effective, and whether the benefits outweigh the risks. An investigational medicine must be studied in humans to make sure it is safe and effective before it can be prescribed to people.

Flu virus changes every year, and that's why yearly vaccination is the most effective way to help prevent flu and its complications.

In this study, we will be working together to see if an investigational medicine is safe to use, and whether it can help people with overweight or obesity to lose weight and manage weight-related conditions. The investigational medicine is a monthly injection that is given subcutaneously (under the skin). Increasing physical activity and reducing the number of calories eaten does not necessarily lead to a reduction in weight for all individuals. As obesity continues to increase, this is a concern, as some diseases are known to occur more often in people with overweight or obesity.